Moderna, Inc. - Common Stock (NQ:MRNA)

153.69 +14.80 (+10.66%)

Streaming Delayed Price Updated: 10:21 AM EDT, Aug 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

99 100 Next >

Why Moderna (MRNA) Stock Is Trading Lower Today

August 01, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 7.1% in the afternoon session after the company trimmed the upper end of its 2025 revenue forecast, citing a delay in vaccine shipments. The...

Via StockStory

Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector ↗

August 01, 2025

Shares of Novavax are trading lower Friday morning. The stock appears to be caught in a downdraft affecting COVID-19 vaccine makers after rival Moderna reported disappointing Q2 results.

Via Benzinga

Which S&P500 stocks are gapping on Friday? ↗

August 01, 2025

Curious about the market action on Friday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Moderna's Earnings: A Preview ↗

July 31, 2025

Via Benzinga

Moderna CEO Attributes Full-Year Revenue Guidance Reduction To Timing Of Shipments: Retail Pins Hopes On Pipeline After Q2 Beat ↗

August 01, 2025

The vaccine maker lowered its full-year revenue guidance to a range of $1.5 billion to $2.2 billion, reflecting a $300 million reduction at the high end of the range.

Via Stocktwits

Topics Artificial Intelligence

Moderna's Key Patent Win Overshadowed By Gloomy Outlook ↗

August 01, 2025

Moderna beat Q2 earnings and revenue estimates, narrowed its annual forecast, won a key patent case, and plans to cut 10% of its global workforce.

Via Benzinga

Topics Intellectual Property

Top S&P500 movers in Friday's pre-market session ↗

August 01, 2025

Curious about the S&P500 stocks that are showing activity before the opening bell on Friday?

Via Chartmill

Moderna (NASDAQ:MRNA) Exceeds Q2 Expectations But Stock Drops

August 01, 2025

Biotechnology company Moderna (NASDAQ:MRNA) reported Q2 CY2025 results exceeding the market’s revenue expectations, but sales fell by 41.1% year on year to $142 million. On the other hand, the...

Via StockStory

Moderna Stock Falls Again Amid Lowered Guidance, Job Cuts ↗

August 01, 2025

The biotech reported a smaller-than-expected Q2 loss and revenue decline.

Via Investor's Business Daily

Topics Artificial Intelligence

Dow Futures Decline As Trump Unleashes Tariffs Globally: AAPL, AMZN, COIN, RDDT, CVX, XOM Among Stocks To Watch ↗

August 01, 2025

While Dow Jones futures were down 0.94% at the time of writing, the S&P 500 futures fell 0.95%.

Via Stocktwits

Topics ETFs Government Stocks

Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates

August 01, 2025

Via ACCESS Newswire

UK Court of Appeal Confirms Moderna’s EP'949 Patent is Valid and Infringed by Pfizer/BioNTech

August 01, 2025

Via ACCESS Newswire

Moderna Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

August 01, 2025

Via Benzinga

Earnings Scheduled For August 1, 2025 ↗

August 01, 2025

Via Benzinga

Moderna Announces 10% Layoffs Ahead Of Q2 Report: Retail Now Eyes ‘Good Enough’ Earnings ↗

July 31, 2025

CEO Stéphane Bancel said in a note to employees on Thursday that the move is part of the company’s commitment to reduce annual operating expenses by about $1.5 billion by 2027.

Via Stocktwits

Topics Artificial Intelligence Supply Chain Workforce

Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles ↗

July 31, 2025

Moderna Inc. (NASDAQ: MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.

Via Benzinga

Moderna Earnings: What To Look For From MRNA

July 30, 2025

Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence Government World Trade

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

July 30, 2025

Via ACCESS Newswire

Oscar Health, Surgery Partners, Moderna, Molina Healthcare, and Fortrea Stocks Trade Down, What You Need To Know

July 29, 2025

A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending...

Via StockStory

Uncover the latest developments among S&P500 stocks in today's session. ↗

July 29, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption' ↗

July 28, 2025

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program (VICP), describing the system as fundamentally broken...

Via Benzinga

Moderna Announces Data to be Presented at ESMO Congress 2025

July 28, 2025

Via ACCESS Newswire

Down 74% Over the Past Year, Is Moderna Stock a Buy? ↗

July 26, 2025

Via The Motley Fool

Biotech Is Booming, and This Undervalued REIT Stands to Gain ↗

July 25, 2025

Via The Motley Fool

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1

July 25, 2025

Via ACCESS Newswire

What's Going On With Moderna Stock Wednesday? ↗

July 23, 2025

Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political uncertainty.

Via Benzinga

Which S&P500 stocks are moving on Wednesday? ↗

July 23, 2025

Let's delve into the developments on the US markets one hour before the close of the markets on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Uncover the latest developments among S&P500 stocks in today's session. ↗

July 23, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Wednesday's session: gap up and gap down stock in the S&P500 index ↗

July 23, 2025

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know

July 18, 2025

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like...

Via StockStory

Topics Lawsuit World Trade

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.